Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses

Arch Dermatol. 2009 Feb;145(2):203-5. doi: 10.1001/archdermatol.2008.562.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Aged
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Antimetabolites, Antineoplastic / adverse effects
  • Female
  • Fluorouracil / administration & dosage*
  • Fluorouracil / adverse effects
  • Follow-Up Studies
  • Humans
  • Keratosis, Actinic / drug therapy*
  • Keratosis, Actinic / pathology
  • Keratosis, Actinic / psychology
  • Male
  • Medication Adherence*
  • Prospective Studies
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Fluorouracil

Associated data

  • ClinicalTrials.gov/NCT00696488